CRWV CoreWeave, Inc. Insider Trading

CDO Brannin McBee sells 53,000 shares for $4,486,098.79 via scheduled 10b5-1 plan; stock down -49.8% from 52-week high.

Brannin McBee, Chief Development Officer, executed 18 separate sales totaling 53,000 shares for $4,486,098.79 on 2026-07-13 at a blended average price of $84.64. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, making it scheduled rather than discretionary. The sale reduces his non-derivative holdings from 104,000 shares to 51,000 shares, though he retains 3,677,227 shares in Canis Major 2025 GRAT and 486,205 shares in Canis Minor 2025 GRAT. The timing coincides with material equity pressure: the stock trades at $77.12, down -49.8% from its 52-week high of $153.50 and down -27.7% over the last 30 days. Against this backdrop, CoreWeave reported $2,078,000,000.00 in latest-quarter revenue and annual revenue growth of +167.9%, but the company remains unprofitable with full-year net income of $-740,000,000.00. The scheduled nature of this sale prevents attribution to discretionary timing judgment, but the scale of the reduction and the concurrent deterioration in both stock price and profitability metrics warrant investor attention.

CDO Brannin McBee sells 197,000 shares for $16.7M via scheduled 10b5-1 plan; retains 11,914,214 derivative holdings across trusts.

Brannin McBee, Chief Development Officer, executed 24 separate sales totaling 197,000 shares (197.0K shares) for $16,674,887.27 ($16.7M) on 2026-07-13 at a blended average price of $84.64. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05 and is therefore scheduled, not discretionary. The sales occur against a backdrop of significant stock weakness: the current price of $77.12 is -49.8% from the 52-week high and down -27.7% over the prior 30 days. Post-transaction, McBee retains 11,914,214 shares across multiple vehicles (Class B Common Stock direct holdings, spouse holdings, and two irrevocable trusts), indicating this represents a scheduled vesting-related partial sale rather than a full position liquidation. CoreWeave remains unprofitable with net income of $-740,000,000.00 against revenue of $2,078,000,000.00 in the latest quarter, though the company posted annual revenue growth of +167.9%.

CoreWeave CFO Nitin Agrawal sells 65,055 shares for $5,512,785.58 via 6 transactions on 2026-07-13 under 10b5-1 plan

Nitin Agrawal, CFO of CoreWeave, Inc., executed 6 separate sales totaling 65,055 shares for $5,512,785.58 on 2026-07-13 under a pre-arranged 10b5-1 trading plan adopted on 2025-08-27. The transaction reduced his holdings by 33.6% to 128,716 shares. His prior 5 trades at CRWV (all on 2026-06-16) each show negative 30-day returns ranging from -28.6% to -32.8%, and since the current stock price of $77.12 is 49.8% off its 52-week high of $153.50 and down 27.7% over 30 days, the timing context reflects significant recent price deterioration at this ticker. The company reported net income of $-740,000,000.00 on revenue of $2,078,000,000.00 in the latest quarter and remains unprofitable on a full-year basis, though annual revenue growth is +167.9%.

CEO Michael N Intrator sold 369,489 shares for $30,803,187.51 in 19 scheduled transactions (2026-07-07 to 2026-07-08) under 10b5-1 plan.

Michael N Intrator, CEO and President, executed 19 separate sales totaling 369,489 shares for $30,803,187.51 between July 7–8, 2026, pursuant to a pre-arranged 10b5-1 trading plan adopted on 2025-11-20. This is a scheduled, non-discretionary transaction. His non-derivative holdings declined by -11.4% vs pre-transaction holdings from 3,246,304 shares to 2,876,815 shares, but he retains 23,341,584 shares in Class B Common Stock through Omnadora Capital LLC (derivative holdings). The company reported revenue of $2,078,000,000.00 in its latest quarter with net income of $-740,000,000.00, and has generated negative full-year net income despite annual revenue growth of +167.9%. The blended average transaction price was $83.37; the current price is $90.00, representing a -45.8% decline from the 52-week high of $166.22.

CDO Brannin McBee sold 53,000 shares for $4.6M across 15 transactions on 2026-07-06 via 10b5-1 plan

Brannin McBee, Chief Development Officer of CoreWeave, executed 15 separate sales totaling 53,000 shares for $4,564,858.12 at a blended average price of $86.13 on 2026-07-06 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-05. This represents a -50.7% reduction in his non-derivative holdings from 104,500 to 51,500 shares, though the insider retains 4,215,932 derivative shares held through two GRATs (Canis Major and Canis Minor). The sale occurred as the stock trades -45.8% below its 52-week high of $166.22 and -12.1% below its 30-day moving average, while the company remains unprofitable with a net loss of $740.0M on revenue of $2,078,000,000.00 in the latest quarter. As a scheduled 10b5-1 transaction, this sale reflects pre-committed programming rather than discretionary market timing, reducing interpretation to adherence to an earlier plan established during a period when the stock may have been positioned differently.

CDO Brannin McBee sold 197,000 shares at $83.09–$87.11 on 2026-07-06 for $16,967,520.52 via 10b5-1 plan; retains 12,111,214 shares in derivative accounts.

Brannin McBee, Chief Development Officer, executed 20 separate sales totaling 197,000 shares for $16,967,520.52 at prices ranging from $83.09 to $87.11 with a blended average of $86.13. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, meaning the sales were scheduled rather than discretionary. Although the non-derivative holdings were fully liquidated (0 shares post-transaction), McBee retains 12,111,214 total shares across four ownership vehicles (Class B Common Stock direct and through spouse, plus two irrevocable trusts). The stock has declined 12.1% over 30 days and is 45.8% below its 52-week high of $166.22. CoreWeave fundamentals show substantial revenue growth of 167.9% on a $2.1B quarterly revenue base, but the company remains unprofitable with a net loss of $-740.0M in the latest period. The systematic execution of a pre-planned sell schedule against a backdrop of operational losses and recent price weakness is noteworthy for investors monitoring executive positioning.

CSO Brian M Venturo sells 76,912 shares ($6.7M) at CoreWeave via 12 transactions under 10b5-1 plan

Brian M Venturo, Chief Strategy Officer, executed 12 separate sales totaling 76,912 shares for $6,690,604.88 on 2026-07-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-11-13, with a blended average price of $86.99. The stock has declined 31.5% over the past 30 days and currently trades at $81.74, down 52.8% from its 52-week high of $173.35. CoreWeave reported $2,078,000,000.00 in revenue for the latest quarter but generated negative net income of -$740,000,000.00, with the company unprofitable over its most recent full fiscal year despite annual revenue growth of +167.9%. The scheduled nature of this divestiture under the 10b5-1 plan removes discretionary timing considerations from the transaction, but the magnitude and the company's loss-making status warrant investor attention.

CEO Michael N Intrator sells 307,692 shares for $30,189,415.67 via 10b5-1 plan on 2026-06-30

Michael N Intrator, CEO and President, executed 12 separate sales totaling 307,692 shares for $30,189,415.67 on 2026-06-30, with a blended average price of $98.12. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-11-20 and is therefore scheduled, not discretionary. The Form 4 indicates a derivative conversion (C) transaction; the insider's full position resides in derivative securities per Table II, which is not yet populated in our database—the non-derivative shares_after of 0 does not represent total holdings. CoreWeave is currently unprofitable with net income of $-740,000,000.00 (latest quarter), though annual revenue growth reached +167.9%. The current stock price of $81.74 is -52.8% from the 52-week high of $173.35 and has declined -31.5% over the past 30 days.

CDO Brannin McBee sells 55,500 shares for $5,234,995.08 via scheduled 10b5-1 plan; holds 4,580,432 derivative shares across trusts.

Brannin McBee, Chief Development Officer, executed 27 separate sales totaling 55,500 shares for $5,234,995.08 on 2026-06-29 at a blended average price of $94.32, pursuant to a pre-arranged 10b5-1 trading plan adopted on 2026-03-05. His non-derivative holdings fell to 0, but he retains 4,580,432 derivative shares held through Class B Common Stock vehicles (Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 GRAT, and Canis Minor 2025 GRAT). The transaction occurred while CRWV's stock has declined -50.6% from its 52-week high of $173.35 and -31.4% over the trailing 30 days, yet the company reported annual revenue growth of +167.9% and revenue of $2,078,000,000.00 in the latest quarter, offset by net income of $-740,000,000.00 showing continued unprofitability. Since this trade is governed by a scheduled 10b5-1 plan rather than discretionary choice, the timing and execution reflect pre-set parameters rather than real-time market assessment.

Chief Development Officer McBee sells 194,000 shares at CRWV for $18.3M across 27 transactions; stock down -50.6% from 52-week high.

Brannin McBee, Chief Development Officer, executed 27 separate sales totaling 194,000 shares for $18,298,925.16 on 2026-06-29, at a blended average price of $94.32. This filing is part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-05, meaning the sales were scheduled rather than discretionary. The transaction reduced his non-derivative holdings to zero; however, McBee retains 11,996,214 shares through derivative holdings across three ownership vehicles (6,474,894 shares direct, 1,980,300 by spouse, and 3,541,020 through his 2022 Irrevocable Trust). The sales occur amid significant stock volatility: CRWV trades at $85.68 currently, -50.6% from its 52-week high of $173.35, and has declined -31.4% over the past 30 days, though it is up +4.2% over 90 days. The company reported $2.1B in latest quarterly revenue with annual revenue growth of +167.9%, yet posted a net loss of $-740.0M and was unprofitable over its most recent full fiscal year, creating a disconnect between revenue scale and profitability that warrants scrutiny.